NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/23/2018
Back to search
Official data from USPTO
BIODIRECT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIODIRECT
ST13
US500000077128455Class
35, 36, 37
Filing
77128455
Registration
3452040
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/23/2018
Trademark type
Word
Nice classes
35, 36, 37
Filing date
03/12/2007
Registration date
06/24/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2018
Last transaction
06/23/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
07/01/2002
First use in commerce
07/01/2002
Drawing code
4
Owner type
03
Owner location
Taunton, MA, US
Examiner
MEIER, SHARON A
Law office
M30
Current location
TMO LAW OFFICE 112
Holders and representatives
Holders
Biodirect Inc.
Representatives
Robert Salter SALTER & MICHAELSON
Technical classification
Nice Classes
Class 35Class 36Class 37
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Electronic catalog services and telephone order taking services for others featuring new and pre-owned laboratory equipment; procurementpurchasing laboratory equipment for others; Remarketing of laboratory equipment for others; business risk management
Class 36
Financial risk management; investment servicesasset management services; fiscal valuationfair market valuations and assessments of laboratory equipment
Class 37
Repair and maintenance of laboratory equipment
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/23/2018
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
06/23/2018
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
06/23/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/22/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
06/12/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/24/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/22/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/22/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/22/2014
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
04/08/2014
E815
TEAS SECTION 8 & 15 RECEIVED
04/08/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
06/24/2008
PUBO
PUBLISHED FOR OPPOSITION
04/08/2008
NPUB
NOTICE OF PUBLICATION
03/19/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/03/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/03/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
02/19/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/01/2008
ALIE
ASSIGNED TO LIE
01/31/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/20/2007
XAEC
EXAMINER'S AMENDMENT ENTERED
12/20/2007
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/20/2007
GNEA
EXAMINERS AMENDMENT E-MAILED
12/20/2007
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/20/2007
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/19/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/19/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/18/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/18/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/28/2007
GNRT
NON-FINAL ACTION E-MAILED
06/28/2007
CNRT
NON-FINAL ACTION WRITTEN
06/28/2007
DOCK
ASSIGNED TO EXAMINER
06/22/2007
NWAP
NEW APPLICATION ENTERED
03/15/2007
Continuous trademark protection
Get notified about every new filing that threatens BIODIRECT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.